StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Short Interest Up 30.5% in August

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) saw a significant growth in short interest in August. As of August 15th, there was short interest totalling 20,100 shares, a growth of 30.5% from the July 31st total of 15,400 shares. Based on an average daily trading volume, of 9,000 shares, the short-interest ratio is presently 2.2 days.

StageZero Life Sciences Stock Performance

OTCMKTS SZLSF remained flat at $0.05 during midday trading on Friday. The company’s stock had a trading volume of 3,398 shares, compared to its average volume of 8,990. StageZero Life Sciences has a 1-year low of $0.00 and a 1-year high of $1.00. The firm has a 50 day simple moving average of $0.02 and a 200-day simple moving average of $0.02.

StageZero Life Sciences Company Profile

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood.